Last reviewed · How we verify
NCT03811301
[BrainConnexion] - Neurodevice Phase I Trial
NA trial testing BrainConnexion in Tetraplegia in 5 participants. Status unknown.
27 January 2023
Quick facts
| Lead sponsor | National Neuroscience Institute |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 5 |
| Start date | 21 November 2017 |
| Primary completion | 27 January 2023 |
| Estimated completion | 27 August 2023 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- BrainConnexion
Conditions studied
- Tetraplegia — all drugs for Tetraplegia →
- Tetraplegia/Tetraparesis — all drugs for Tetraplegia/Tetraparesis →
- Spinal Cord Injuries — all drugs for Spinal Cord Injuries →
- Amyotrophic Lateral Sclerosis — all drugs for Amyotrophic Lateral Sclerosis →
Sponsor
National Neuroscience Institute
Who can join
21 and older, any sex, with Tetraplegia or Tetraplegia/Tetraparesis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the safety of a wireless implantable neurodevice microsystem in tetraplegic patients, as well as the efficacy of the electrodes for long-term recording of neural activities and the successful control of an external device.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03811301
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tetraplegia
Currently open trials in the same condition.
- NCT07058506 — Control Interfaces for Operating Assistive Devices · NA · recruiting
- NCT06511934 — Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01) · NA · recruiting
- NCT06288763 — Nerve Transfer to Improve Function in High Level Tetraplegia · recruiting
- NCT06094205 — Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02) · NA · recruiting
- NCT05553457 — MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury · NA · recruiting
Other National Neuroscience Institute trials
Trials by the same sponsor.
- NCT05824546 — uSINE-PAMS Artificial Intelligence Driven, Ultrasound-Guided Lumbar Puncture to Improve Procedural Accuracy · NA · recruiting
- NCT05644171 — RESTORES Trial: RESToration Of Rehabilitative Function With Epidural Spinal Stimulation · NA · recruiting
- NCT03711903 — Evaluation of CN-105 in Subject With Acute Supratentorial Intracerebral Hemorrhage · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03811301 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Neuroscience Institute
- Last refreshed: 6 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03811301.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing